Skip to main content

iRhythm Holdings, Inc.

For the period ended Dec 31, 2025. Filed Feb 19, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 19, 2026

IRTC$86.06-3.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits, Financial Statement Schedules

The following documents are filed as part of this Annual Report on Form 10-K:

(1)Financial Statements

The financial statements filed as part of this Annual Report on Form 10-K are listed in the “Index to Financial Statements” under Part II, Item 8 of this Annual Report on Form 10-K.

(2)Financial Statement Schedules

Financial statement schedules have been omitted in this Annual Report on Form 10-K because they are not applicable, not required under the instructions, or the information requested is set forth in the financial statements or related notes thereto.

(3) Exhibits

The following is a list of exhibits filed with this Annual Report on Form 10-K incorporated herein by reference (numbered in accordance with Item 601 of Regulation S-K).

Exhibit Index
Incorporated by Reference
ExhibitNumberExhibit TitleFormFile No.ExhibitFiling DateProvided Herewith
3.1Amended and Restated Certificate of Incorporation of the Registrant dated January 12, 2026.8-K12B001-379183.1January 12, 2026
3.2Amended and Restated Bylaws of the Registrant dated January 12, 2026.8-K12B001-379183.2January 12, 2026
4.1Description of the Registrant's securities registered pursuant to Section 12 of the Exchange Act.8-K12B001-379184.1January 12, 2026
4.2Indenture dated March 7, 2024 between the Registrant and U.S. Bank Trust Company, NA, as trustee (including the form 1.50% Convertible Senior Notes due 2029).8-K001-379184.1March 8, 2024
4.3First Supplemental Indenture dated January 12, 2026 between iRhythm Technologies, Inc., iRhythm Holdings, Inc. as Guarantor, and U.S. Bank Trust Company, NA, as trustee.8-K12B001-379184.2January 12, 2026
10.1Office Lease dated October 4, 2018 between the Registrant and Big Dog Holdings LLC.10-K001-3791810.35March 4, 2019
10.2First Amendment to Office Lease dated May 31, 2019 between the Registrant and Big Dog Holdings LLC.10-K001-3791810.10February 22, 2024
10.3Multi-Tenant Office/Industrial Lease by and between iRhythm Technologies, Inc. and Katella/Holder Street LLC dated March 18, 2021.10-Q001-3791810.42May 10, 2021
10.4+*2016 Equity Incentive Plan, and related form agreements.X
10.5+*2016 Employee Stock Purchase Plan.X
10.6+*2006 Equity Incentive Plan, and related form agreementsX
10.7+Executive Incentive Compensation Plan of the Registrant.S-1/A333-21377310.5October 7, 2016
10.8+*Form of Indemnification Agreement for directors and executive officers.X
10.9+Amended and Restated Executive Change in Control and Severance Policy of the Registration.X
10.10+Offer Letter, dated September 8, 2021, by and between the Registrant and Quentin S. Blackford.8-K001-3791810.1September 13, 2021
10.11+Offer Letter, dated November 15, 2021, by and between the Registrant and Patrick Murphy.10-K001-3791810.19February 23, 2023
10.12+Offer Letter, dated April 24, 2022, by and between the Registrant and Minang Pravin Turakhia, MD.10-K001-3791810.20February 23, 2023
10.13+Offer Letter, dated July 18,2022, by and between the Registrant and Chad Patterson.10-K001-3791810.21February 23, 2023
10.14+Offer Letter dated June 28, 2019, as amended August 1, 2024, by and between the Registrant and Daniel Wilson.10-K001-3791810.2February 20, 2025
10.15±Technology License Agreement dated August 30, 2024 between the Registrant and BioIntelliSense, Inc.10-Q001-3791810.1October 30, 2024
10.16Assignment and Assumption Agreement dated January 12, 2026 between iRhythm Holdings, Inc. and iRhythm Technologies Inc.8-K12B001-3791810.1January 12, 2026
19.1 *Insider Trading Policy of the Registrant.X
21.1List of Subsidiaries of the Registrant.X
22.1Subsidiary Issuers of Guaranteed Securities.X
23.1Consent of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP, San Jose, CA)X
31.1†Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
31.2†Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
32.1†Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
97.1 *Compensation Recovery Policy of the Registrant.X
101.INSInline XBRL Instance Document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document

†The certification attached as 32.1 that accompanies this Annual Report on Form 10-K, is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of iRhythm Holdings, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing.

  • Indicates management contract or compensatory plan.

± Confidential treatment has been requested for portions of this exhibit.The Registrant agrees to furnish supplementally a copy of the omitted schedules and exhibits to the SEC upon request.

  • These exhibits are being filed to reflect the assumption of these agreements and documents by the Registrant following the Holding Company Transaction.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.